Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R William Watson

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Nature Reviews. Urology|July 4, 2012
Patented prostate cancer biomarkersLisa Murphy, R William Watson
Acta Paediatrica (Oslo, Norway : 1992)|February 20, 2013
Toll-like receptors in neonatal sepsisFiona M O'Hare, R William Watson, Eleanor J Molloy
Expert Review of Molecular Diagnostics|February 26, 2015
Commercialized biomarkers: new horizons in prostate cancer diagnosticsLisa Murphy, Maria Prencipe, William M Gallagher, et al.
Oncotarget|October 27, 2017
MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancerEmma Dorris, Amanda O'Neill, Karen Hanrahan, et al.
BJU International|February 16, 2011
Epstein criteria for insignificant prostate cancerSheng F Oon, R William Watson, John J O'Leary, et al.
BJU International|April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancerKarim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Cancers|October 26, 2017
Advances in Precision Medicine: Tailoring Individualized TherapiesKyle B Matchett, Niamh Lynam-Lennon, R William Watson, et al.
The Journal of Urology|January 25, 2003
Endothelin in unilateral ureteral obstruction: vascular and cellular effectsNicholas J Hegarty, Leonie S Young, Amanda J O'Neill, et al.
Journal of Clinical Pathology|August 24, 2019
Pathology in Irish medical educationHilary Humphreys, Niall Stevens, Desmond Leddin, et al.
Oncotarget|March 18, 2020
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancerEmma R Dorris, Amanda O'Neill, Ann Treacy, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Nature Reviews. Urology|July 4, 2012
Patented prostate cancer biomarkersLisa Murphy, R William Watson
Acta Paediatrica (Oslo, Norway : 1992)|February 20, 2013
Toll-like receptors in neonatal sepsisFiona M O'Hare, R William Watson, Eleanor J Molloy
Expert Review of Molecular Diagnostics|February 26, 2015
Commercialized biomarkers: new horizons in prostate cancer diagnosticsLisa Murphy, Maria Prencipe, William M Gallagher, et al.
Oncotarget|October 27, 2017
MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancerEmma Dorris, Amanda O'Neill, Karen Hanrahan, et al.
BJU International|February 16, 2011
Epstein criteria for insignificant prostate cancerSheng F Oon, R William Watson, John J O'Leary, et al.
BJU International|April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancerKarim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Cancers|October 26, 2017
Advances in Precision Medicine: Tailoring Individualized TherapiesKyle B Matchett, Niamh Lynam-Lennon, R William Watson, et al.
The Journal of Urology|January 25, 2003
Endothelin in unilateral ureteral obstruction: vascular and cellular effectsNicholas J Hegarty, Leonie S Young, Amanda J O'Neill, et al.
Journal of Clinical Pathology|August 24, 2019
Pathology in Irish medical educationHilary Humphreys, Niall Stevens, Desmond Leddin, et al.
Oncotarget|March 18, 2020
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancerEmma R Dorris, Amanda O'Neill, Ann Treacy, et al.
Pageof 4